Windtree Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$8.11 | -$8.11 | -$8.11 |
| Q2 2024 | 1 | -$2.27 | -$2.27 | -$2.27 |
| Q3 2024 | 1 | -$1.14 | -$1.14 | -$1.14 |
| Q1 2025 | 1 | -$3.60 | -$3.60 | -$3.60 |
| Q2 2025 | 1 | -$1.98 | -$1.98 | -$1.98 |
| Q3 2025 | 1 | -$1.08 | -$1.08 | -$1.08 |
| Q4 2025 | 1 | $0.36 | $0.36 | $0.36 |
Windtree Therapeutics, Inc. Earnings Date And Information
Windtree Therapeutics, Inc. last posted its earnings results on Monday, August 19th, 2024. The company reported $-20.91 earnings per share for the quarter, missing analysts' consensus estimates of $-8.11 by $12.8. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Windtree Therapeutics, Inc. has generated $-92 earnings per share over the last year ($-92.23 diluted earnings per share) and currently has a price-to-earnings ratio of -0.02. Windtree Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based on prior year's report dates.
Windtree Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/19/2024 | Q2 2024 | -$8.11 | -$20.91 | -12.8 | $0 | $0 |
| 03/29/2024 | Q1 2024 | $21.98 | $0 | |||
| 12/30/2023 | Q4 2023 | -$17.18 | $0 | |||
| 11/09/2023 | Q3 2023 | -$0.63 | -$15.26 | -14.63 | $0 | |
| 08/07/2023 | Q2 2023 | -$0.68 | -$30.00 | -29.32 | $0 | |
| 05/15/2023 | Q1 2023 | -$0.56 | -$91.90 | -91.34 | $0 | |
| 03/31/2023 | Q4 2022 | -$242.30 | $0 | |||
| 11/14/2022 | Q3 2022 | -$269.78 | -$115.40 | 154.38 | $50,000 | $0 |
| 08/11/2022 | Q2 2022 | -$98.92 | -$534.24 | -435.32 | $200,000 | $0 |
| 05/05/2022 | Q1 2022 | -$278.78 | -$258.48 | 20.3 | $0 | |
| 03/31/2022 | Q4 2021 | -$296.76 | -$417.96 | -121.2 | $0 | |
| 11/10/2021 | Q3 2021 | -$269.78 | -$279.00 | -9.22 | $0 | |
| 08/05/2021 | Q2 2021 | -$467.63 | -$1,278.00 | -810.37 | $0 | |
| 05/13/2021 | Q1 2021 | -$15.00 | -$459.00 | -444 | $0 | |
| 03/29/2021 | Q4 2020 | -$377.70 | -$387.00 | -9.3 | $23.68 M | |
| 11/16/2020 | Q3 2020 | -$440.65 | -$486.00 | -45.35 | $0 | |
| 08/14/2020 | Q2 2020 | -$567.00 | $0 | |||
| 05/13/2020 | Q1 2020 | -$23.85 | $0 | |||
| 04/02/2020 | Q4 2019 | -$31.98 | $0 | |||
| 11/14/2019 | Q3 2019 | -$33.21 | $0 |
Windtree Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Windtree Therapeutics, Inc.'s earnings date?
Windtree Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates.
-
How can I listen to Windtree Therapeutics, Inc.'s earnings conference call?
The conference call for Windtree Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Windtree Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Windtree Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Windtree Therapeutics, Inc. generate each year?
Windtree Therapeutics, Inc. (:WINT) has a recorded net income of $0. Windtree Therapeutics, Inc. has generated $-92.23 earnings per share over the last four quarters.
-
What is Windtree Therapeutics, Inc.'s price-to-earnings ratio?
Windtree Therapeutics, Inc. (:WINT) has a price-to-earnings ratio of -0.02 and price/earnings-to-growth ratio is -0.
